EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) EBITDA (2010 - 2026)

EyePoint (EYPT) posted EBITDA of -$87.2 million for Q1 2026, down 24.0% sequentially from -$70.3 million in Q4 2025, and down 78.61% YoY from -$407.7 million in Q1 2025.

Analysis

EyePoint (EYPT) EBITDA (2010 - 2026) Analysis & Trends

EyePoint has reported EBITDA for 17 years, with the latest figure at -$87.2 million in Q1 2026.

  • Quarterly EBITDA fell 78.61% year-over-year to -$87.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$281.8 million (down 74.64% YoY) and the FY2025 annual result came in at -$243.4 million, down 66.9% from the prior year.
  • EBITDA slipped to -$87.2 million in Q1 2026 per EYPT's latest filing, from -$70.3 million in the prior quarter.
  • Over five years, EBITDA peaked at -$14.4 million in Q3 2023 and troughed at -$87.2 million in Q1 2026.
  • A 5-year average of -$38.3 million and a median of -$33.3 million in 2024 frame the typical range for EBITDA.
  • The sharpest annual moves came in 2023 and 2024: EBITDA jumped 62.61% in 2023, then slumped 176.62% in 2024.
  • Over 5 years, EBITDA stood at -$43.7 million in 2022, then surged by 62.61% to -$16.4 million in 2023, then tumbled by 176.62% to -$45.2 million in 2024, then sank by 55.5% to -$70.3 million in 2025, then declined by 24.0% to -$87.2 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods registered -$87.2 million, -$70.3 million, and -$62.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 133.12 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -1.55 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 -97.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -97.38 Mn
Mar 31, 2026 -87.23 Mn
Dec 31, 2025 -70.35 Mn
Sep 30, 2025 -62.03 Mn
Jun 30, 2025 -62.23 Mn
Mar 31, 2025 -48.84 Mn
Dec 31, 2024 -45.24 Mn
Sep 30, 2024 -32.75 Mn
Jun 30, 2024 -34.55 Mn
Mar 31, 2024 -33.32 Mn
Dec 31, 2023 -16.35 Mn
Sep 30, 2023 -14.40 Mn
Jun 30, 2023 -22.76 Mn
Mar 31, 2023 -21.55 Mn
Dec 31, 2022 -43.74 Mn
Sep 30, 2022 -18.40 Mn
Jun 30, 2022 -19.22 Mn
Mar 31, 2022 -18.28 Mn
Dec 31, 2021 -18.05 Mn
Sep 30, 2021 -15.31 Mn